img

Global Carbetocin (Duratocin) Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Carbetocin (Duratocin) Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Carbetocin (Duratocin) market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Carbetocin (Duratocin) market research.
Key manufacturers engaged in the Carbetocin (Duratocin) industry include Beacon Pharmaceuticals Limited, Ferring Inc., Polypeptide Laboraries France, Chemos GmbH & Co. KG, Hangzhou Dayangchem Co. Ltd., Acinopeptide Co., Ltd., Bachem AG, Clearsynth Canada INC. and Leap Labchem Co., Ltd, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Carbetocin (Duratocin) were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Carbetocin (Duratocin) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Carbetocin (Duratocin) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Beacon Pharmaceuticals Limited
Ferring Inc.
Polypeptide Laboraries France
Chemos GmbH & Co. KG
Hangzhou Dayangchem Co. Ltd.
Acinopeptide Co., Ltd.
Bachem AG
Clearsynth Canada INC.
Leap Labchem Co., Ltd
Chemieliva Pharmaceutical Co., Ltd.
Acinopeptide Co., Ltd.
BOC Sciences
Segment by Type
Carbetocin Tablets
Carbetocin Injection

Segment by Application


Oxytocic
Antihemorrhagic
Uterotonic

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Carbetocin (Duratocin) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Carbetocin (Duratocin) Market Overview
1.1 Product Overview and Scope of Carbetocin (Duratocin)
1.2 Carbetocin (Duratocin) Segment by Type
1.2.1 Global Carbetocin (Duratocin) Market Value Comparison by Type (2024-2034)
1.2.2 Carbetocin Tablets
1.2.3 Carbetocin Injection
1.3 Carbetocin (Duratocin) Segment by Application
1.3.1 Global Carbetocin (Duratocin) Market Value by Application: (2024-2034)
1.3.2 Oxytocic
1.3.3 Antihemorrhagic
1.3.4 Uterotonic
1.4 Global Carbetocin (Duratocin) Market Size Estimates and Forecasts
1.4.1 Global Carbetocin (Duratocin) Revenue 2018-2034
1.4.2 Global Carbetocin (Duratocin) Sales 2018-2034
1.4.3 Global Carbetocin (Duratocin) Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Carbetocin (Duratocin) Market Competition by Manufacturers
2.1 Global Carbetocin (Duratocin) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Carbetocin (Duratocin) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Carbetocin (Duratocin) Average Price by Manufacturers (2018-2023)
2.4 Global Carbetocin (Duratocin) Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Carbetocin (Duratocin), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Carbetocin (Duratocin), Product Type & Application
2.7 Carbetocin (Duratocin) Market Competitive Situation and Trends
2.7.1 Carbetocin (Duratocin) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Carbetocin (Duratocin) Players Market Share by Revenue
2.7.3 Global Carbetocin (Duratocin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Carbetocin (Duratocin) Retrospective Market Scenario by Region
3.1 Global Carbetocin (Duratocin) Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Carbetocin (Duratocin) Global Carbetocin (Duratocin) Sales by Region: 2018-2034
3.2.1 Global Carbetocin (Duratocin) Sales by Region: 2018-2023
3.2.2 Global Carbetocin (Duratocin) Sales by Region: 2024-2034
3.3 Global Carbetocin (Duratocin) Global Carbetocin (Duratocin) Revenue by Region: 2018-2034
3.3.1 Global Carbetocin (Duratocin) Revenue by Region: 2018-2023
3.3.2 Global Carbetocin (Duratocin) Revenue by Region: 2024-2034
3.4 North America Carbetocin (Duratocin) Market Facts & Figures by Country
3.4.1 North America Carbetocin (Duratocin) Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Carbetocin (Duratocin) Sales by Country (2018-2034)
3.4.3 North America Carbetocin (Duratocin) Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Carbetocin (Duratocin) Market Facts & Figures by Country
3.5.1 Europe Carbetocin (Duratocin) Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Carbetocin (Duratocin) Sales by Country (2018-2034)
3.5.3 Europe Carbetocin (Duratocin) Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Carbetocin (Duratocin) Market Facts & Figures by Country
3.6.1 Asia Pacific Carbetocin (Duratocin) Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Carbetocin (Duratocin) Sales by Country (2018-2034)
3.6.3 Asia Pacific Carbetocin (Duratocin) Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Carbetocin (Duratocin) Market Facts & Figures by Country
3.7.1 Latin America Carbetocin (Duratocin) Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Carbetocin (Duratocin) Sales by Country (2018-2034)
3.7.3 Latin America Carbetocin (Duratocin) Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Carbetocin (Duratocin) Market Facts & Figures by Country
3.8.1 Middle East and Africa Carbetocin (Duratocin) Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Carbetocin (Duratocin) Sales by Country (2018-2034)
3.8.3 Middle East and Africa Carbetocin (Duratocin) Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Carbetocin (Duratocin) Sales by Type (2018-2034)
4.1.1 Global Carbetocin (Duratocin) Sales by Type (2018-2023)
4.1.2 Global Carbetocin (Duratocin) Sales by Type (2024-2034)
4.1.3 Global Carbetocin (Duratocin) Sales Market Share by Type (2018-2034)
4.2 Global Carbetocin (Duratocin) Revenue by Type (2018-2034)
4.2.1 Global Carbetocin (Duratocin) Revenue by Type (2018-2023)
4.2.2 Global Carbetocin (Duratocin) Revenue by Type (2024-2034)
4.2.3 Global Carbetocin (Duratocin) Revenue Market Share by Type (2018-2034)
4.3 Global Carbetocin (Duratocin) Price by Type (2018-2034)
5 Segment by Application
5.1 Global Carbetocin (Duratocin) Sales by Application (2018-2034)
5.1.1 Global Carbetocin (Duratocin) Sales by Application (2018-2023)
5.1.2 Global Carbetocin (Duratocin) Sales by Application (2024-2034)
5.1.3 Global Carbetocin (Duratocin) Sales Market Share by Application (2018-2034)
5.2 Global Carbetocin (Duratocin) Revenue by Application (2018-2034)
5.2.1 Global Carbetocin (Duratocin) Revenue by Application (2018-2023)
5.2.2 Global Carbetocin (Duratocin) Revenue by Application (2024-2034)
5.2.3 Global Carbetocin (Duratocin) Revenue Market Share by Application (2018-2034)
5.3 Global Carbetocin (Duratocin) Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Beacon Pharmaceuticals Limited
6.1.1 Beacon Pharmaceuticals Limited Corporation Information
6.1.2 Beacon Pharmaceuticals Limited Description and Business Overview
6.1.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Portfolio
6.1.5 Beacon Pharmaceuticals Limited Recent Developments/Updates
6.2 Ferring Inc.
6.2.1 Ferring Inc. Corporation Information
6.2.2 Ferring Inc. Description and Business Overview
6.2.3 Ferring Inc. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ferring Inc. Carbetocin (Duratocin) Product Portfolio
6.2.5 Ferring Inc. Recent Developments/Updates
6.3 Polypeptide Laboraries France
6.3.1 Polypeptide Laboraries France Corporation Information
6.3.2 Polypeptide Laboraries France Description and Business Overview
6.3.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Polypeptide Laboraries France Carbetocin (Duratocin) Product Portfolio
6.3.5 Polypeptide Laboraries France Recent Developments/Updates
6.4 Chemos GmbH & Co. KG
6.4.1 Chemos GmbH & Co. KG Corporation Information
6.4.2 Chemos GmbH & Co. KG Description and Business Overview
6.4.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Portfolio
6.4.5 Chemos GmbH & Co. KG Recent Developments/Updates
6.5 Hangzhou Dayangchem Co. Ltd.
6.5.1 Hangzhou Dayangchem Co. Ltd. Corporation Information
6.5.2 Hangzhou Dayangchem Co. Ltd. Description and Business Overview
6.5.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Portfolio
6.5.5 Hangzhou Dayangchem Co. Ltd. Recent Developments/Updates
6.6 Acinopeptide Co., Ltd.
6.6.1 Acinopeptide Co., Ltd. Corporation Information
6.6.2 Acinopeptide Co., Ltd. Description and Business Overview
6.6.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
6.6.5 Acinopeptide Co., Ltd. Recent Developments/Updates
6.7 Bachem AG
6.6.1 Bachem AG Corporation Information
6.6.2 Bachem AG Description and Business Overview
6.6.3 Bachem AG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bachem AG Carbetocin (Duratocin) Product Portfolio
6.7.5 Bachem AG Recent Developments/Updates
6.8 Clearsynth Canada INC.
6.8.1 Clearsynth Canada INC. Corporation Information
6.8.2 Clearsynth Canada INC. Description and Business Overview
6.8.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Clearsynth Canada INC. Carbetocin (Duratocin) Product Portfolio
6.8.5 Clearsynth Canada INC. Recent Developments/Updates
6.9 Leap Labchem Co., Ltd
6.9.1 Leap Labchem Co., Ltd Corporation Information
6.9.2 Leap Labchem Co., Ltd Description and Business Overview
6.9.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Portfolio
6.9.5 Leap Labchem Co., Ltd Recent Developments/Updates
6.10 Chemieliva Pharmaceutical Co., Ltd.
6.10.1 Chemieliva Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Chemieliva Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Portfolio
6.10.5 Chemieliva Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Acinopeptide Co., Ltd.
6.11.1 Acinopeptide Co., Ltd. Corporation Information
6.11.2 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Description and Business Overview
6.11.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
6.11.5 Acinopeptide Co., Ltd. Recent Developments/Updates
6.12 BOC Sciences
6.12.1 BOC Sciences Corporation Information
6.12.2 BOC Sciences Carbetocin (Duratocin) Description and Business Overview
6.12.3 BOC Sciences Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BOC Sciences Carbetocin (Duratocin) Product Portfolio
6.12.5 BOC Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Carbetocin (Duratocin) Industry Chain Analysis
7.2 Carbetocin (Duratocin) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Carbetocin (Duratocin) Production Mode & Process
7.4 Carbetocin (Duratocin) Sales and Marketing
7.4.1 Carbetocin (Duratocin) Sales Channels
7.4.2 Carbetocin (Duratocin) Distributors
7.5 Carbetocin (Duratocin) Customers
8 Carbetocin (Duratocin) Market Dynamics
8.1 Carbetocin (Duratocin) Industry Trends
8.2 Carbetocin (Duratocin) Market Drivers
8.3 Carbetocin (Duratocin) Market Challenges
8.4 Carbetocin (Duratocin) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Carbetocin (Duratocin) Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Carbetocin (Duratocin) Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Carbetocin (Duratocin) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Carbetocin (Duratocin) Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Carbetocin (Duratocin) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Carbetocin (Duratocin) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Carbetocin (Duratocin) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Carbetocin (Duratocin) Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Carbetocin (Duratocin), Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Carbetocin (Duratocin), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Carbetocin (Duratocin), Product Type & Application
Table 12. Global Key Manufacturers of Carbetocin (Duratocin), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Carbetocin (Duratocin) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbetocin (Duratocin) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Carbetocin (Duratocin) Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Carbetocin (Duratocin) Sales by Region (2018-2023) & (K Pcs)
Table 18. Global Carbetocin (Duratocin) Sales Market Share by Region (2018-2023)
Table 19. Global Carbetocin (Duratocin) Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Carbetocin (Duratocin) Sales Market Share by Region (2024-2034)
Table 21. Global Carbetocin (Duratocin) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Carbetocin (Duratocin) Revenue Market Share by Region (2018-2023)
Table 23. Global Carbetocin (Duratocin) Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Carbetocin (Duratocin) Revenue Market Share by Region (2024-2034)
Table 25. North America Carbetocin (Duratocin) Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Carbetocin (Duratocin) Sales by Country (2018-2023) & (K Pcs)
Table 27. North America Carbetocin (Duratocin) Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Carbetocin (Duratocin) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Carbetocin (Duratocin) Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Carbetocin (Duratocin) Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Carbetocin (Duratocin) Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe Carbetocin (Duratocin) Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Carbetocin (Duratocin) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Carbetocin (Duratocin) Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Carbetocin (Duratocin) Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Carbetocin (Duratocin) Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific Carbetocin (Duratocin) Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Carbetocin (Duratocin) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Carbetocin (Duratocin) Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Carbetocin (Duratocin) Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Carbetocin (Duratocin) Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America Carbetocin (Duratocin) Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Carbetocin (Duratocin) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Carbetocin (Duratocin) Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Carbetocin (Duratocin) Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Carbetocin (Duratocin) Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa Carbetocin (Duratocin) Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Carbetocin (Duratocin) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Carbetocin (Duratocin) Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Carbetocin (Duratocin) Sales (K Pcs) by Type (2018-2023)
Table 51. Global Carbetocin (Duratocin) Sales (K Pcs) by Type (2024-2034)
Table 52. Global Carbetocin (Duratocin) Sales Market Share by Type (2018-2023)
Table 53. Global Carbetocin (Duratocin) Sales Market Share by Type (2024-2034)
Table 54. Global Carbetocin (Duratocin) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Carbetocin (Duratocin) Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Carbetocin (Duratocin) Revenue Market Share by Type (2018-2023)
Table 57. Global Carbetocin (Duratocin) Revenue Market Share by Type (2024-2034)
Table 58. Global Carbetocin (Duratocin) Price (USD/Pcs) by Type (2018-2023)
Table 59. Global Carbetocin (Duratocin) Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Carbetocin (Duratocin) Sales (K Pcs) by Application (2018-2023)
Table 61. Global Carbetocin (Duratocin) Sales (K Pcs) by Application (2024-2034)
Table 62. Global Carbetocin (Duratocin) Sales Market Share by Application (2018-2023)
Table 63. Global Carbetocin (Duratocin) Sales Market Share by Application (2024-2034)
Table 64. Global Carbetocin (Duratocin) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Carbetocin (Duratocin) Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Carbetocin (Duratocin) Revenue Market Share by Application (2018-2023)
Table 67. Global Carbetocin (Duratocin) Revenue Market Share by Application (2024-2034)
Table 68. Global Carbetocin (Duratocin) Price (USD/Pcs) by Application (2018-2023)
Table 69. Global Carbetocin (Duratocin) Price (USD/Pcs) by Application (2024-2034)
Table 70. Beacon Pharmaceuticals Limited Corporation Information
Table 71. Beacon Pharmaceuticals Limited Description and Business Overview
Table 72. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product
Table 74. Beacon Pharmaceuticals Limited Recent Developments/Updates
Table 75. Ferring Inc. Corporation Information
Table 76. Ferring Inc. Description and Business Overview
Table 77. Ferring Inc. Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. Ferring Inc. Carbetocin (Duratocin) Product
Table 79. Ferring Inc. Recent Developments/Updates
Table 80. Polypeptide Laboraries France Corporation Information
Table 81. Polypeptide Laboraries France Description and Business Overview
Table 82. Polypeptide Laboraries France Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Polypeptide Laboraries France Carbetocin (Duratocin) Product
Table 84. Polypeptide Laboraries France Recent Developments/Updates
Table 85. Chemos GmbH & Co. KG Corporation Information
Table 86. Chemos GmbH & Co. KG Description and Business Overview
Table 87. Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Chemos GmbH & Co. KG Carbetocin (Duratocin) Product
Table 89. Chemos GmbH & Co. KG Recent Developments/Updates
Table 90. Hangzhou Dayangchem Co. Ltd. Corporation Information
Table 91. Hangzhou Dayangchem Co. Ltd. Description and Business Overview
Table 92. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product
Table 94. Hangzhou Dayangchem Co. Ltd. Recent Developments/Updates
Table 95. Acinopeptide Co., Ltd. Corporation Information
Table 96. Acinopeptide Co., Ltd. Description and Business Overview
Table 97. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product
Table 99. Acinopeptide Co., Ltd. Recent Developments/Updates
Table 100. Bachem AG Corporation Information
Table 101. Bachem AG Description and Business Overview
Table 102. Bachem AG Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Bachem AG Carbetocin (Duratocin) Product
Table 104. Bachem AG Recent Developments/Updates
Table 105. Clearsynth Canada INC. Corporation Information
Table 106. Clearsynth Canada INC. Description and Business Overview
Table 107. Clearsynth Canada INC. Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Clearsynth Canada INC. Carbetocin (Duratocin) Product
Table 109. Clearsynth Canada INC. Recent Developments/Updates
Table 110. Leap Labchem Co., Ltd Corporation Information
Table 111. Leap Labchem Co., Ltd Description and Business Overview
Table 112. Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. Leap Labchem Co., Ltd Carbetocin (Duratocin) Product
Table 114. Leap Labchem Co., Ltd Recent Developments/Updates
Table 115. Chemieliva Pharmaceutical Co., Ltd. Corporation Information
Table 116. Chemieliva Pharmaceutical Co., Ltd. Description and Business Overview
Table 117. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product
Table 119. Chemieliva Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Acinopeptide Co., Ltd. Corporation Information
Table 121. Acinopeptide Co., Ltd. Description and Business Overview
Table 122. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product
Table 124. Acinopeptide Co., Ltd. Recent Developments/Updates
Table 125. BOC Sciences Corporation Information
Table 126. BOC Sciences Description and Business Overview
Table 127. BOC Sciences Carbetocin (Duratocin) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 128. BOC Sciences Carbetocin (Duratocin) Product
Table 129. BOC Sciences Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Carbetocin (Duratocin) Distributors List
Table 133. Carbetocin (Duratocin) Customers List
Table 134. Carbetocin (Duratocin) Market Trends
Table 135. Carbetocin (Duratocin) Market Drivers
Table 136. Carbetocin (Duratocin) Market Challenges
Table 137. Carbetocin (Duratocin) Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Carbetocin (Duratocin)
Figure 2. Global Carbetocin (Duratocin) Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Carbetocin (Duratocin) Market Share by Type in 2024 & 2034
Figure 4. Carbetocin Tablets Product Picture
Figure 5. Carbetocin Injection Product Picture
Figure 6. Global Carbetocin (Duratocin) Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Carbetocin (Duratocin) Market Share by Application in 2024 & 2034
Figure 8. Oxytocic
Figure 9. Antihemorrhagic
Figure 10. Uterotonic
Figure 11. Global Carbetocin (Duratocin) Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Carbetocin (Duratocin) Market Size (2018-2034) & (US$ Million)
Figure 13. Global Carbetocin (Duratocin) Sales (2018-2034) & (K Pcs)
Figure 14. Global Carbetocin (Duratocin) Average Price (USD/Pcs) & (2018-2034)
Figure 15. Carbetocin (Duratocin) Report Years Considered
Figure 16. Carbetocin (Duratocin) Sales Share by Manufacturers in 2024
Figure 17. Global Carbetocin (Duratocin) Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Carbetocin (Duratocin) Players: Market Share by Revenue in 2024
Figure 19. Carbetocin (Duratocin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Carbetocin (Duratocin) Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Carbetocin (Duratocin) Sales Market Share by Country (2018-2034)
Figure 22. North America Carbetocin (Duratocin) Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Carbetocin (Duratocin) Sales Market Share by Country (2018-2034)
Figure 26. Europe Carbetocin (Duratocin) Revenue Market Share by Country (2018-2034)
Figure 27. Germany Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Carbetocin (Duratocin) Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Carbetocin (Duratocin) Revenue Market Share by Region (2018-2034)
Figure 34. China Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Carbetocin (Duratocin) Sales Market Share by Country (2018-2034)
Figure 45. Latin America Carbetocin (Duratocin) Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Carbetocin (Duratocin) Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Carbetocin (Duratocin) Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. U.A.E Carbetocin (Duratocin) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Carbetocin (Duratocin) by Type (2018-2034)
Figure 55. Global Revenue Market Share of Carbetocin (Duratocin) by Type (2018-2034)
Figure 56. Global Carbetocin (Duratocin) Price (USD/Pcs) by Type (2018-2034)
Figure 57. Global Sales Market Share of Carbetocin (Duratocin) by Application (2018-2034)
Figure 58. Global Revenue Market Share of Carbetocin (Duratocin) by Application (2018-2034)
Figure 59. Global Carbetocin (Duratocin) Price (USD/Pcs) by Application (2018-2034)
Figure 60. Carbetocin (Duratocin) Value Chain
Figure 61. Carbetocin (Duratocin) Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed